Earnings Data
Report Date
Oct 29, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.53Last Year’s EPS
-0.85Same Quarter Last Year
Strong Buy
Based on 17 Analysts Ratings
DE:2CL Q2 2026 Earnings Report
DE:2CL Upcoming Earnings
BridgeBio Pharma's next earnings date is estimated for October 29, 2026, based on past reporting schedules.
DE:2CL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:2CL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 10, 2026 | €73.81 | €73.29 | -0.70% |
May 07, 2026 | €58.03 | €59.00 | +1.67% |
Feb 24, 2026 | €57.10 | €58.84 | +3.05% |
Oct 29, 2025 | €55.86 | €57.42 | +2.79% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BridgeBio Pharma Inc (DE:2CL) report earnings?
BridgeBio Pharma Inc (DE:2CL) is schdueled to report earning on Oct 29, 2026, After Close (Confirmed).
What is BridgeBio Pharma Inc (DE:2CL) earnings time?
BridgeBio Pharma Inc (DE:2CL) earnings time is at Oct 29, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of BridgeBio Pharma Inc stock?
The P/E ratio of BridgeBio Pharma is N/A.
What is DE:2CL EPS forecast?
DE:2CL EPS forecast for the fiscal quarter 2026 (Q3) is -0.53.